ANIK – anika therapeutics inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ANIK

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/4

11:12 pm

anik

Anika Therapeutics, Inc. (NASDAQ: ANIK) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.

Low Report

Anika Therapeutics, Inc. (NASDAQ: ANIK) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.

Report

11/1

10:34 am

anik

Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $37.00 to $25.00. They now have an "outperform" rating on the stock.

Low Report

Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $37.00 to $25.00. They now have an "outperform" rating on the stock.

Report

11/1

07:29 am

anik

Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]

Medium Report

Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]

Report

10/31

11:00 am

anik

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics

Medium Report

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics

Report

10/31

07:11 am

anik

Anika Reports Third Quarter 2024 Financial Results [Yahoo! Finance]

High Report

Anika Reports Third Quarter 2024 Financial Results [Yahoo! Finance]

Report

10/31

07:05 am

anik

Anika Reports Third Quarter 2024 Financial Results

High Report

Anika Reports Third Quarter 2024 Financial Results

Report

10/31

07:00 am

anik

Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

High Report

Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

Report

10/22

10:46 am

anik

Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.

Low Report

Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.

Report

10/17

04:01 pm

anik

Anika Announces Third Quarter 2024 Results Conference Call Date

Low Report

Anika Announces Third Quarter 2024 Results Conference Call Date

Report

10/4

04:01 pm

anik

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Low Report

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Report

9/17

07:43 am

anik

Adhesion Barrier Market to Reach $1.5 Billion, Globally, by 2033 at 7.8% CAGR: Allied Market Research [Yahoo! Finance]

Low Report

Adhesion Barrier Market to Reach $1.5 Billion, Globally, by 2033 at 7.8% CAGR: Allied Market Research [Yahoo! Finance]

Report

9/9

04:45 pm

anik

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Low Report

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Report

8/15

04:01 pm

anik

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Low Report

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Report

8/13

09:30 am

anik

Sidoti Events, LLC's Virtual August Micro-Cap Conference

Low Report

Sidoti Events, LLC's Virtual August Micro-Cap Conference

Report

8/13

12:35 am

anik

[Latest] Global Aesthetics Injectables Market Size/Share Worth USD 35,976.2 Million by 2033 at a 9.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) [Yahoo! Finance]

Low Report

Report

8/11

02:18 am

anik

Anika Therapeutics, Inc (ANIK) Q2 2024 Earnings Call Transcript [Seeking Alpha]

Low Report

Anika Therapeutics, Inc (ANIK) Q2 2024 Earnings Call Transcript [Seeking Alpha]

Report

8/10

10:18 am

anik

Anika Therapeutics, Inc. (NASDAQ:ANIK) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates [Yahoo! Finance]

Low Report

Anika Therapeutics, Inc. (NASDAQ:ANIK) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates [Yahoo! Finance]

Report

8/9

06:12 pm

anik

Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.

Low Report

Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.

Report

8/9

07:49 am

anik

Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock? [Yahoo! Finance]

Neutral Report

Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock? [Yahoo! Finance]

Report

8/8

08:45 pm

anik

Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates [Yahoo! Finance]

Neutral Report

Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates [Yahoo! Finance]

Report

8/8

04:05 pm

anik

Anika Reports Second Quarter 2024 Financial Results

Neutral Report

Anika Reports Second Quarter 2024 Financial Results

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.